American Pharmacy News
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • Home
  • »
  • Stories
  • »
  • Industry

Pharmacy association's executive director responds to DIR fee report

American Pharmacy News Reports | Aug 15, 2017
Sheila Arquette said the study is one of many in a long line paid for by pharmacy benefit managers.

National Association of Specialty Pharmacy Executive Director Sheila Arquette recently responded to a report on direct and indirect remuneration fees commissioned by the Pharmaceutical Care Management Association. Read More »

Pharmacy Times ranks highest for ad visibility and readership

American Pharmacy News Reports | Aug 10, 2017
Pharmacy Times’ departments work together to deliver content on the evolving pharmacy industry.

Pharmacy Times, the leading media resource for pharmacists and the pharmacy industry, ranked highest in ad visibility and highest in readership in the 2017 Kantar Media Pharmacy Readership study. Read More »

Dexrazoxane from Cumberland Pharmaceuticals approved for U.S. oncology patients

American Pharmacy News Reports | Aug 8, 2017
Totect is approved by the U.S. Food and Drug Administration as an oncology intervention.

Cumberland Pharmaceuticals, specializing in therapies for underserved populations, has begun shipping its Totect brand of dexrazoxane, for alleviating certain side effects of chemotherapy during cancer treatment, to U.S. wholesalers. Read More »

Zoetis acquires Nexvet Biopharma for pet pain management products

American Pharmacy News Reports | Aug 8, 2017
Zoetis’ product line features chronic pain management meds for dogs and cats.

Animal health specialist firm Zoetis of Parsippany, New Jersey recently completed an approximately $85 million acquisition of Irish biologic therapeutics business Nexvet Biopharma PLC, with the deal expected to boost the company’s market share. Read More »

Spectrum Pharmacy Products and IPA form partnership

American Pharmacy News Reports | Aug 8, 2017
Spectrum will offer IPA members some of the broadest selection of compounding chemicals in the industry.

Spectrum Pharmacy Products, a top manufacturer and distributor of pharmaceutical chemicals and supplies, is partnering with the Independent Pharmacy Alliance (IPA), a retail pharmacy and trade group that represents thousands of pharmacies in the Northeastern U.S., PR Newswire reported. Read More »

Innovus Pharma seeks to release hemorrhoid pain relief cream in Canada

American Pharmacy News Reports | Aug 7, 2017
The drug is a

Innovus Pharmaceuticals Inc., an expanding commercial-stage medication company that provides over-the-counter products for both men and women, will be filing a product licence application in Canada for its drug, Xyralid. Read More »

LabCorp to acquire Chiltern in $1.2 billion cash deal

American Pharmacy News Reports | Aug 7, 2017
Chiltern expects 2017 revenue of approximately $550 million.

LabCorp, a provider of diagnostic solutions and breakthrough medicines, recently announced plans for its all-cash acquisition of international contract research firm Chiltern of England for approximately $1.2 billion, enhancing LabCorp’s portfolio and capabilities. Read More »

Insys Therapeutics rolls out ‘milestone’ Syndros formula

American Pharmacy News Reports | Aug 6, 2017
Dronabinol is a pharmaceutical cannabinoid.

Phoenix-based Insys Therapeutics Inc. recently revealed that its new branded liquid formulation Syndros (dronabinol oral solution) is on the market to address side effects of AIDS and chemotherapy such as weight loss and related symptoms. Read More »

Biologics named limited distributor of Nerlynx

American Pharmacy News Reports | Aug 6, 2017
Biologics uses a “high-touch care model” emphasizing a team approach to the patient’s experience.

Los Angeles-based Puma Biotechnology Inc.’s FDA-approved Nerlynx (neratinib) tablets — a kinase inhibitor developed to treat breast cancer — will be circulated by Cary, North Carolina’s Biologics Inc. as per a limited distribution agreement between the companies. Read More »

Vizient releases Drug Price Forecast for 2018

Mark Iandolo | Aug 6, 2017
Health systems should see a 7.61 percent average increase in price on pharmaceutical purchases in 2018.

Vizient Inc. recently released its July 2017 Drug Price Forecast, which provides pharmacy leaders and health system executives with insights on pricing and practice changes throughout the pharmaceutical industry. Read More »

EnvisionRx receives renewed accreditation from URAC

American Pharmacy News Reports | Aug 4, 2017
EnvisionRx has URAC accreditation for drug therapy management.

EnvisionRx, a pharmacy benefit manager (PBM) and division of EnvisionRxOptions, a wholly owned subsidiary of Rite Aid Corporation, recently announced that the health care accrediting organization URAC renewed the company’s accreditation for pharmacy benefit management. Read More »

Accord acquires rights to sell Custodiol HTK Solution

American Pharmacy News Reports | Aug 3, 2017
The acquisition gives Accord the rights to sell Custodiol HTK Solution.

Accord Healthcare has acquired Essential Pharmaceuticals, a New Jersey company that provides products, services and contributions to transplant medicine. Read More »

Luminex Corp.'s c. difficile assay attains FDA clearance

American Pharmacy News Reports | Jul 31, 2017
C. difficile is an urgent threat as it is now the most common microbial cause of health care-associated infections in U.S. hospitals.

Luminex Corporation recently announced that its ARIES clostridium difficile (c. difficile) assay has been given U.S. Food and Drug Administration (FDA) clearance. Read More »

Therigy partners with EPI-W to expand research on specialty pharmacy outcomes

American Pharmacy News Reports | Jul 28, 2017
Therigy noted that EPI-Q brings more than 20 years of experience to the research table.

Therigy, a company that pioneered patient-focused specialty therapy management, recently announced a strategic partnership with EPI-Q Inc. to expand research on specialty pharmacy outcomes. Read More »

AstraZeneca taps Biologics to distribute carcinoma drug

American Pharmacy News Reports | Jul 28, 2017
Patients diagnosed with advance bladder cancer often start receiving platinum-containing chemotherapy.

Biologics Inc., a McKesson Specialty Health oncology pharmacy services company, has been chosen by AstraZeneca to distribute Imfinzi. Read More »

Optum and Merck simulate contractual reimbursement models

American Pharmacy News Reports | Jul 26, 2017
The companies will use a shared laboratory to explore both value-based and pay-for-performance models.

Optum, UnitedHealth Group’s health services business, and Merck recently announced collaboration on developing and simulating the performance of contractual reimbursement models that align payment for prescription drugs with patient health outcomes. Read More »

Amgen, Array BioPharma pool efforts to attack autoimmune disorders

American Pharmacy News Reports | Jul 25, 2017
Array BioPharma leaders referred to Amgen as “a leader in treatments for inflammatory disease.”

Amgen of Thousand Oaks, California and Array BioPharma of Boulder, Colorado recently created a cooperative contract to develop innovative drugs aimed at combating autoimmune disorders after Array’s breakthrough discovery of certain target and lead inhibitors. Read More »

Australian institutes pool resources to treat diabetes, obesity

American Pharmacy News Reports | Jul 25, 2017
UniQuest specializes in commercializing intellectual property and research results.

Launching a four-year research program to develop diabetes and obesity treatments, PreveCeutical Medical Inc. of Vancouver, British Columbia recently signed an agreement with UniQuest Pty Ltd. of the University of Queensland in Australia. Read More »

GE Healthcare attains Novia Strategies to build capacity for improved outcomes

American Pharmacy News Reports | Jul 22, 2017
GE Healthcare Camden Group has served over 2,400 health care facilities and systems.

Joining forces with experienced clinicians from Novia Strategies, GE Healthcare recently acquired the 22-year-old California-founded consulting group to enhance its capability for driving optimal outcomes through organizational improvement. Read More »

AmeriHealth Caritas Louisiana earns NCQA distinction

American Pharmacy News Reports | Jul 22, 2017
AmeriHealth Caritas Louisiana strives to serve all populations.

Demonstrating excellence in overcoming cultural barriers to quality care, Medicaid managed health care plan AmeriHealth Caritas Louisiana of Baton Rouge recently merited an honor from the National Committee for Quality Assurance (NCQA). Read More »

  • «
  • 1
  • 2
  • ...
  • 14
  • 15
  • 16 (current)
  • 17
  • 18
  • ...
  • 32
  • 33
  • »
Trending

Sally Pipes, President & CEO of Pacific Research Institute

Pacific Research Institute CEO on 340B Drug Pricing Program: 'Inject some badly needed transparency into 340B'

West Cuthbert, Senior Fellow, American Resolve Action

American Resolve Action Senior Fellow on 340B reform: Oversight 'could prevent billions of dollars in annual waste, fraud, and abuse'

Jonathan Levitt, Founding Partner, Frier Levitt

Frier Levitt partner on CVS Health 340B lawsuits: CVS diverted funds ‘designated to help safety-net hospitals care for the most vulnerable’

B. Douglas Hoey CEO

NCPA supports pharmacy bills being marked up in House committees

Brian Hanna, Executive Director of the Cannabis Regulatory Agency

Cannabis Regulatory Agency seeks new members for diversity, equity, and inclusion workgroup

Copyright © 2026 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up